| INOVIO PHARMACEUTICAL INC |
| USA |
| Gesundheit |
| US45773H4092 / A400EJ |
| GBM (Frankfurt) / INO (NASDAQ) |
| FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO |
| - |
| https://inovio.com/ |
|
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing DNA medicines for treating and protecting against HPV-related diseases, cancer, and infectious diseases. The company employs proprietar..
>Volltext.. |
| 69 Mio. EUR |
| 43.91 Mio. EUR |
| - |
| -66.12 Mio. EUR |
| -58.47 Mio. EUR |
| -1.02 EUR |
| 6.94 Mio. EUR |
| 27.34 Mio. EUR |
| -69.88 Mio. EUR |
| 0.92 |
| -100% |
| 20.75% |
| - |
| - |
| - |
| - |
| INOVIO |
| 14.08.26 |
|